Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA. 2015;65(2):87–108. doi:10.3322/caac.21262
   Web of Science ®Google Scholar
• Group G. Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis. Eur J Cancer. 2013;49(7):1565–77.
   PubMed Web of Science ®Google Scholar
• Yamashita H, Katai H. Systemic inflammatory response in gastric cancer. World J Surg. 2010;34(10):2399–400. doi:10.1007/s00268-010-0703-1
   PubMed Web of Science ®Google Scholar
• Liu X, Sun X, Liu J, Kong P, Chen S, Zhan Y, Xu D. Preoperative C-reactive protein/albumin ratio predicts prognosis of patients after curative resection for gastric cancer. Transl Oncol. 2015;8(4):339–45. doi:10.1016/j.tranon.2015.06.006
   PubMed Web of Science ®Google Scholar
• Nie R, Yuan S, Chen S, Chen X, Chen Y, Zhu B, Qiu H, Zhou Z, Peng J, Chen Y. Prognostic nutritional index is an independent prognostic factor for gastric cancer patients with peritoneal dissemination. Chinese J Cancer Res. 2016;28(6):570–8. doi:10.21147/j.issn.1000-9604.2016.06.03
   PubMed Web of Science ®Google Scholar
• Aurello P, Tierno SM, Berardi G, Tomassini F, Magistri P, D’Angelo F, Ramacciato G. Value of preoperative inflammation-based prognostic scores in predicting overall survival and disease-free survival in patients with gastric cancer. Ann Surg Oncol. 2014;21(6):1998–2004. doi:10.1245/s10434-014-3533-9
   PubMed Web of Science ®Google Scholar
• Orditura M. Treatment of gastric cancer. WJG. 2014;20(7):1635–49. doi:10.3748/wjg.v20.i7.1635
   PubMed Web of Science ®Google Scholar
• He X, Zhou T, Yang Y, Hong S, Zhan J, Hu Z, Fang W, Qin T, Ma Y, Zhao Y. Advanced lung cancer inflammation index, a new prognostic score, predicts outcome in patients with small-cell lung cancer. Clin Lung Cancer. 2015;16(6):e165–e171. doi:10.1016/j.cllc.2015.03.005
   PubMed Web of Science ®Google Scholar
• Martin L, Birdsell L, MacDonald N, Reiman T, Clandinin MT, McCargar LJ, Murphy R, Ghosh S, Sawyer MB, Baracos VE. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. JCO. 2013;31(12):1539–47. JCO. 2012.45. 2722. doi:10.1200/JCO.2012.45.2722
   PubMed Web of Science ®Google Scholar
• Prado CMM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629–35. doi:10.1016/S1470-2045(08)70153-0
   PubMed Web of Science ®Google Scholar
• Baracos VE, Reiman T, Mourtzakis M, Gioulbasanis I, Antoun S. Body composition in patients with non–small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr. 2010;91(4):1133S–7S. doi:10.3945/ajcn.2010.28608C
   PubMed Web of Science ®Google Scholar
• Miyamoto Y, Baba Y, Sakamoto Y, Ohuchi M, Tokunaga R, Kurashige J, Hiyoshi Y, Iwagami S, Yoshida N, Yoshida M. Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol. 2015;22(8):2663–8. doi:10.1245/s10434-014-4281-6
   PubMed Web of Science ®Google Scholar
• Jafri SHR, Previgliano C, Khandelwal K, Shi R. Cachexia index in advanced non-small-cell lung cancer patients. Clin Med Insights. Oncol. 2015;9:87.
   PubMed Web of Science ®Google Scholar
• Mourtzakis M, Prado CMM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33(5):997–1006. doi:10.1139/H08-075
   PubMed Web of Science ®Google Scholar
• Sun X, Liu X, Liu J, Chen S, Xu D, Li W, Zhan Y, Li Y, Chen Y, Zhou Z. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I–II gastric cancer. Chin J Cancer. 2016;35(1):57. doi:10.1186/s40880-016-0122-2
   PubMedGoogle Scholar
• Liu H, Song M, Fang F, Gao XUE, Zhang Z, Wang S. Prediction of chemotherapeutic efficacy using the ratio of neutrophils to lymphocytes in patients with unresectable or recurrent gastric cancer. Oncol Lett. 2015;10(4):2244–8. doi:10.3892/ol.2015.3575
   PubMed Web of Science ®Google Scholar
• Wang S-L, Zhuang C-L, Huang D-D, Pang W-Y, Lou N, Chen F-F, Zhou C-J, Shen X, Yu Z. Sarcopenia adversely impacts postoperative clinical outcomes following gastrectomy in patients with gastric cancer: a prospective study. Ann Surg Oncol. 2016;23(2):556–64. doi:10.1245/s10434-015-4887-3
   PubMed Web of Science ®Google Scholar
• Chau I, Norman AR, Cunningham D, Waters JS, Oates J, Ross PJ. Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer—pooled analysis from three multicenter, randomized, controlled trials using individual patient data. JCO. 2004;22(12):2395–403. doi:10.1200/JCO.2004.08.154
   PubMed Web of Science ®Google Scholar
• Kanagavel D, Pokataev IA, Fedyanin MY, Tryakin AA, Bazin IS, Narimanov MN, Yakovleva ES, Garin AM, Tjulandin SA. A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy. Ann Oncol. 2010;21(9):1779–85. doi:10.1093/annonc/mdq032
   PubMed Web of Science ®Google Scholar
• Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. JCO. 2006;24(18):2903–9. doi:10.1200/JCO.2005.05.0245
   PubMed Web of Science ®Google Scholar
• Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO, Engstrom PF, Ezdinli EZ. Prognostic effect of weight loss prior tochemotherapy in cancer patients. Am J Med. 1980;69(4):491–7. doi:10.1016/S0149-2918(05)80001-3
   PubMed Web of Science ®Google Scholar
• Jun DH, Kim BJ, Park JH, Kim JG, Chi K-C, Park J-M, Kim MK, Kang H. Preoperative body mass index may determine the prognosis of advanced gastric cancer. Nutr Cancer. 2016;68(8):1295–300. doi:10.1080/01635581.2016.1224363
   PubMed Web of Science ®Google Scholar
• Chen S, Nie R-C, OuYang L-Y, Li Y-F, Xiang J, Zhou Z-W, Chen YBo, Peng J. Body mass index (BMI) may be a prognostic factor for gastric cancer with peritoneal dissemination. World J Surg Onc. 2017;15(1):52. doi:10.1186/s12957-016-1076-1
   PubMed Web of Science ®Google Scholar
• Onate-Ocana LF, Aiello-Crocifoglio V, Gallardo-Rincon D, Herrera-Goepfert R, Brom-Valladares R, Carrillo JF, Cervera E, Mohar-Betancourt A. Serum albumin as a significant prognostic factor for patients with gastric carcinoma. Ann Surg Oncol. 2007;14(2):381–9.
   PubMed Web of Science ®Google Scholar
• Kim J-P, Lee J-H, Kim S-J, Yu H-J, Yang H-K. Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer. Gastric Cancer. 1998;1(2):125–33. doi:10.1007/s101200050006
   PubMedGoogle Scholar
• Slaviero KA, Clarke SJ, Rivory LP. Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy. Lancet Oncol. 2003;4(4) :224–32. doi:10.1016/S1470-2045(03)01034-9
   PubMed Web of Science ®Google Scholar
• Kong F, Gao F, Chen J, Zheng R, Liu H, Li X, Yang P, Liu G, Jia Y. Elevated serum C-reactive protein level predicts a poor prognosis for recurrent gastric cancer. Oncotarget. 2016;7(34):55765. doi:10.18632/oncotarget.9910
   PubMedGoogle Scholar
• Sun J, Chen X, Gao P, Song Y, Huang X, Yang Y, Zhao J, Ma B, Gao X, Wang Z. Can the neutrophil to lymphocyte ratio be used to determine gastric cancer treatment outcomes? A systematic review and meta-analysis. Dis Markers. 2016;2016:1–10. doi:10.1155/2016/7862469
   Web of Science ®Google Scholar
• Kargın S, Çakır M, Gündeş E, Yavuz Y, Esen H, İyisoy MS, Kökbudak N, Küçükkartallar T. Gastrointestinal stromal tümörlerde prognozun belirlenmesinde preoperatif nötrofil lenfosit oranının etkisi. Ulusal Cerrahi Dergisi. 2015;31(2):61–4.
   PubMedGoogle Scholar
• Wang D-s, Luo H-y, Qiu M-z, Wang Z-q, Zhang D-s, Wang F-h, Li Y-h, Xu R-h. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med Oncol. 2012;29(5):3092–100. doi:10.1007/s12032-012-0226-8
   PubMed Web of Science ®Google Scholar
• Kacan T, Babacan NA, Seker M, Yucel B, Bahceci A, Eren AA, Eren MF, Kilickap S. Could the neutrophil to lymphocyte ratio be a poor prognostic factor for non small cell lung cancers? Asian Pacific J Cancer Prev. 2014;15(5):2089–94. doi:10.7314/APJCP.2014.15.5.2089
   PubMedGoogle Scholar
• Kos FT, Hocazade C, Kos M, Uncu D, Karakas E, Dogan M, Uncu HG, Ozdemir N, Zengin N. Assessment of prognostic value of “neutrophil to lymphocyte ratio” and “prognostic nutritional index” as a sytemic inflammatory marker in non-small cell lung cancer. Asian Pac J Cancer Prev. 2015;16(9):3997–4002. doi:10.7314/APJCP.2015.16.9.3997
   PubMedGoogle Scholar
• Jafri SH, Shi R, Mills G. Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review. BMC Cancer. 2013;13(1):1. doi:10.1186/1471-2407-13-158
   PubMed Web of Science ®Google Scholar
• Feng J-F, Huang Y, Chen QX. A new inflammation index is useful for patients with esophageal squamous cell carcinoma. OncoTargets Ther. 2014;7:1811.
   PubMed Web of Science ®Google Scholar
• Jafri SHR, Previgliano C, Khandelwal K, Shi R. Cachexia index in advanced non-small-cell lung cancer patients. Clin Med Insights Oncol. 2015;9:CMO.S30891. doi:10.4137/CMO.S30891
   Web of Science ®Google Scholar
• Kazemi-Bajestani SMR, Mazurak VC, Baracos V. Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes. Semin Cell Dev Biol. 2016;54:2–10. doi:10.1016/j.semcdb.2015.09.001
   PubMed Web of Science ®Google Scholar
• Zhuang C-L, Huang D-D, Pang W-Y, Zhou C-J, Wang S-L, Lou N, Ma L-L, Yu Z, Shen X. Sarcopenia is an independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer: Analysis from a Large-Scale Cohort. Medicine. 2016;95(13):e3164. doi:10.1097/MD.0000000000003164
   PubMed Web of Science ®Google Scholar
• Lou N, Chi C-H, Chen X-D, Zhou C-J, Wang S-L, Zhuang C-L, Shen X. Sarcopenia in overweight and obese patients is a predictive factor for postoperative complication in gastric cancer: A prospective study. Eur J Surg Oncol. 2017;43(1):188–95. doi:10.1016/j.ejso.2016.09.006
   PubMed Web of Science ®Google Scholar
• Bahat G, Tufan A, Tufan F, Kilic C, Akpinar TS, Kose M, Erten N, Karan MA, Cruz-Jentoft AJ. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr. 2016;35(6):1557–63. doi:10.1016/j.clnu.2016.02.002
   PubMed Web of Science ®Google Scholar
• Kovarik M, Hronek M, Zadak Z. Clinically relevant determinants of body composition, function and nutritional status as mortality predictors in lung cancer patients. Lung Cancer. 2014;84(1):1–6. doi:10.1016/j.lungcan.2014.01.020
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel J-P, Rolland Y, Schneider SM. Sarcopenia: European consensus on definition and diagnosis Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–23. doi:10.1093/ageing/afq034
   PubMed Web of Science ®Google Scholar
• Harada K, Ida S, Baba Y, Ishimoto T, Kosumi K, Tokunaga R, Izumi D, Ohuchi M, Nakamura K, Kiyozumi Y. Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma. Dis Esophagus. 2016;29(6):627–33. doi:10.1111/dote.12381
   PubMed Web of Science ®Google Scholar
• Liu X, Qiu H, Kong P, Zhou Z, Sun X. gastric cancer, nutritional status, and outcome. OTT. 2017;10:2107–14. doi:10.2147/OTT.S132432
   Web of Science ®Google Scholar
• Li Q-Q, Lu Z-H, Yang L, Lu M, Zhang X-T, Li J, Zhou J, Wang X-C, Gong J-F, Gao J. Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy. Asian Pacific J Cancer Prev. 2014;15(2):945–50. doi:10.7314/APJCP.2014.15.2.945
   PubMedGoogle Scholar
• Miyazaki T, Yamasaki N, Tsuchiya T, Matsumoto K, Kunizaki M, Taniguchi D, Nagayasu T. Inflammation-based scoring is a useful prognostic predictor of pulmonary resection for elderly patients with clinical stage I non-small-cell lung cancer. Eur J Cardio-Thoracic Surg. 2015;47(4):ezu514–e145. doi:10.1093/ejcts/ezu514
   Web of Science ®Google Scholar
• Nakamura M, Iwahashi M, Nakamori M, Ojima T, Katsuda M, Iida T, Hayata K, Kato T, Yamaue H. A new prognostic score for the survival of patients with esophageal squamous cell carcinoma. Surg Today. 2014;44(5):875–83. doi:10.1007/s00595-013-0628-z
   PubMed Web of Science ®Google Scholar
• Yamada S, Fujii T, Yabusaki N, Murotani K, Iwata N, Kanda M, Tanaka C, Nakayama G, Sugimoto H, Koike M. Clinical implication of inflammation-based prognostic score in pancreatic cancer: glasgow prognostic score is the most reliable parameter. Medicine. 2016;95(18):e3582. doi:10.1097/MD.0000000000003582
   PubMed Web of Science ®Google Scholar